Delivery Order SPE2DR25D3016-SPE2DR26FG1CD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $45,488.56 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This competitive, non-set-aside delivery order utilizes firm fixed-price pricing and represents a continuation of the pharmaceutical supply relationship between DLA and the prime contractor. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count) with a ceiling value of $5,275.63. This competitive, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $26,399.23 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count units) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,885.35 delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count) on September 9, 2025, with completion expected by September 10, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a small-value transaction typical of pharmaceutical procurement under AmerisourceBergen's broader federal contract portfolio, which emphasizes...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,472.58 with firm fixed pricing and an ultimate completion date of July 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,968.48 for Dapagliflozin 10 mg tablets (30-count packaging) on November 14, 2025, with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a specific pharmaceutical fulfillment under DLA's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,998.97 for Dapagliflozin 10 mg tablets (30-count units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single pharmaceutical procurement under the company's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count packaging) valued at $2,525.75 under a firm fixed-price contract type. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location and will deliver...
- The Defense Logistics Agency awarded a delivery order valued at $6,756.65 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count units) valued at $15,245.22 under a firm fixed price arrangement. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG1CDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,490.04 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order was issued on November 14, 2025, with an ultimate completion date of November 17, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. No set-aside designation was applied to this procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare systems worldwide. As a major pharmaceutical distributor with extensive federal contracting experience, AmerisourceBergen fulfills critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/14/25 |